Johnson & Johnson (BVC:JNJ)

Colombia flag Colombia · Delayed Price · Currency is COP
774,800
0.00 (0.00%)
At close: Dec 5, 2025
13.10%
Market Cap 1,863.72T
Revenue (ttm) 360.28T
Net Income (ttm) 98.21T
Shares Out n/a
EPS (ttm) 40,458.24
PE Ratio 18.98
Forward PE 18.00
Dividend 20,693.85 (2.67%)
Ex-Dividend Date Nov 25, 2025
Volume 2
Average Volume 15
Open n/a
Previous Close 774,800
Day's Range n/a
52-Week Range 594,047 - 787,000
Beta n/a
RSI 70.81
Earnings Date Jan 21, 2026

About Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizo... [Read more]

Industry Pharmaceutical Preparations
Founded 1886
Employees 138,100
Stock Exchange Colombia Stock Exchange
Ticker Symbol JNJ
Full Company Profile

Financial Performance

In 2024, Johnson & Johnson's revenue was $88.82 billion, an increase of 4.30% compared to the previous year's $85.16 billion. Earnings were $14.07 billion, a decrease of -59.99%.

Financial numbers in USD Financial Statements

News

There is no news available yet.